International Workshop on Molecular Medicine of Sphingolipids 2014

The aim of this workshop is to connect basic science with pre-clinical models, clinical applications and studies and industry-development of novel drugs. Since sphingolipids are becoming a major target in various very important diseases, in particular autoimmune, infectious, pulmonary, cardiovascular and tumor diseases, it is very important to connect basic scientists with clinicians and applied scientists in the field, to re-shape drug development and the planning of pre cilinical and clinical studies and to promote the transfer of basic science into clinical projects.

CONFIRMED SPEAKERS
Niklas Beyersdorf, University of Würzburg, Würzburg, German
Malcolm Brodlie, Newcastle University, UK
Bernhard Brüne, University of Frankfurt, Germany
Paola Bruni, University of Florence, Italy
Gregory Czarnota, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
Ingrid Fleming, Goethe University, Frankfurt am Main, Germany
Volkmar Gieselman, University of Bonn, Germany
Sabine Groesch, University Hospital Frankfurt, Goethe University,Frankfurt am Main, Germany
Daniel Higginson, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Yoshio Hirabayashi, RIKEN, Wako City, Saitama, Japan
Tim Hla, Weill Cornell Medical College, New York, NY, USA
Walter Holleran, UCSF, San Francisco, CA, USA
Andrea Huwiler, University of Bern, Switzerland
Mark Kester, Penn State College of Medicine, Hershey, USA
Burkhard Kleuser, University of Potsdam, Germany
Alexander Koch, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany
Martin Krönke, Universität zu Köln, Germany
Alex B. Lentsch, University of Cincinnati, College of Medicine, OH, USA

and many more...